Skip to main content Skip to main navigation menu Skip to site footer
Page Header Logo
  • Home
  • About
    • About the Journal
    • Aims & scope
    • Editorial Board
    • Contact Information
  • Current
  • Archives
  • Indexing & Abstracting
  • For Authors
    • Author Guidelines
    • Peer Review Policy
    • Ethical Consideration
    • Publication Ethics and Malpractice Statement
    • Publication Fees
    • Submissions
Search
  • Register
  • Login
  1. Home /
  2. Search

Advanced filters
Th1-Th17 Ratio as a New Insight in Rheumatoid Arthritis Disease
Hadi Bazzazi, Mehrdad Aghaei, Ali Memarian, Hossein Asgarian-Omran, Nasser Behnampour, Yaghoub Yazdani
Published: 2018-02-26
Elevated Expression of Tim-3 and PD-1 Immune Checkpoint Receptors on T-CD4+ Lymphocytes of Patients with Asthma
Ali Mosayebian, Zohreh Koohini, Hadi Hossein-Nataj, Saeid Abediankenari, Siavash Abedi, Hossein Asgarian-Omran
Published: 2018-12-02
Cytologic Phenotypes of B-Cell Acute Lymphoblastic Leukemia-
Ramyar Asghar, Shafiei Masoud, Rezaei Nima, Asgarian-Omran Hossein, Abdar Esfahani Shadi, Moazzami Kasra, Sarafnejad Abdolfattah, Aghamohammadi Asghar
Detection of Novel Autoantibodies to Nucleolin's RNA-binding Domains as a Serum Tumor Biomarker Through ELISA
Fatemeh Ezzatifar, Alireza Rafiei, Reza Valadan, Hossein Asgarian-Omran, Mahmood Jeddi-Tehrani
Published: 2022-12-24
The Effects of PI3K/Akt/mTOR Signaling Pathway Inhibitors on the Expression of Immune Checkpoint Ligands in Acute Myeloid Leukemia Cell Line
Saeid Taghiloo, Saeid Norozi, Hossein Asgarian-Omran
Published: 2022-04-11
CD8+ T-cells Co-expressing PD-1 and TIGIT Are Highly Frequent in Chronic Lymphocytic Leukemia PD-1 and TIGIT Co-expression in CLL
Reza Hajiasghar-Sharbaf, Hossein Asgarian-Omran, Reza Valadan, Hadi Hossein-Nattaj, Ramin Shekarriz, Ehsan Zaboli, Ghasem Janbabaei, Mohsen Tehrani
Published: 2021-12-08
1 - 6 of 6 items


2021 Impact Factor: 1.570
2021 CiteScore: 2.1


pISSN: 1735-1502
eISSN: 1735-5249


Chairman:
Mostafa Moin, M.D. 

Editors-in-Chief:
Mohammad Bagher Eslami, PhD.
Shahnaz Rafiei Tehrani, M.D., Ph.D. 

This journal is a member of, and subscribes to the principles of, the Committee on Publication Ethics (COPE).

2.1
2021CiteScore
 
 
23rd percentile
Powered by  Scopus

 

SCImago Journal & Country Rank

Make a Submission
Information
  • Publication Fee
  • For Readers
  • For Authors
  • For Librarians
Iranian Journal of Allergy, Asthma and Immunology (Bimonthly), pISSN: 1735-1502, eISSN: 1735-5249
Tehran University of Medical Sciences, Tehran, Iran.

All the work in this journal are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.